Ancient dna uncovers herpesviruses embedded in human genomes

Scientists have reconstructed ancient genomes of human herpesviruses HHV-6A and HHV-6B from over 2,000-year-old European remains, proving these viruses have coexisted with humans for at least 2,500 years. The study reveals that some individuals inherited the viruses directly in their DNA, passed down through generations. One strain, HHV-6A, appears to have lost its ability to integrate into human chromosomes over time.

An international team of researchers, led by the University of Vienna and the University of Tartu in Estonia, has provided the first direct genetic evidence of a long-standing relationship between humans and human betaherpesviruses 6A and 6B (HHV-6A/B). Published in Science Advances, the findings stem from analyzing nearly 4,000 skeletal samples from archaeological sites across Europe. From this effort, the team successfully rebuilt eleven ancient herpesvirus genomes, dating back more than 2,000 years.

The oldest sample comes from a young girl in Iron Age Italy, between 1100 and 600 BCE. Other remains span medieval periods in England, Belgium, and Estonia, as well as ancient Italy and early historic Russia. Notably, several individuals from England carried inherited forms of HHV-6B, marking the earliest known cases of chromosomally integrated human herpesviruses. The site of Sint-Truiden in Belgium yielded the most cases, showing both viral strains circulated in the same community.

HHV-6B, which infects about 90 percent of children by age two and causes roseola infantum—the leading trigger for febrile seizures in toddlers—along with HHV-6A, belongs to a family of herpesviruses that establish lifelong dormancy after initial mild infections. Unlike most, these viruses can insert their genetic material into human chromosomes, allowing rare vertical transmission from parent to child. Today, roughly one percent of people carry such inherited copies.

"While HHV-6 infects almost 90% of the human population at some point in their life, only around 1% carry the virus, which was inherited from your parents, in all cells of their body," explained lead researcher Meriam Guellil from the University of Vienna's Department of Evolutionary Anthropology. "Based on our data, the viruses' evolution can now be traced over more than 2,500 years across Europe, using genomes from the 8th-6th century BCE until today."

Comparisons with modern data indicate some integrations happened thousands of years ago and persisted across generations. The study also highlights divergent paths: HHV-6A seems to have forfeited its integration capability early on, altering its host interactions as both evolved.

Links to contemporary health issues emerge too. "Carrying a copy of HHV6B in your genome has been linked to angina-heart-disease," noted Charlotte Houldcroft from the University of Cambridge's Department of Genetics. Inherited forms are more prevalent in the UK than elsewhere in Europe, and this research offers the first ancient evidence from Britain.

Overall, the work timestamps virus-human coevolution at the DNA level, illuminating how childhood infections can embed in our genetic legacy. Although identified in the 1980s, HHV-6's roots now extend to the Iron Age, supporting suspicions of coexistence since humans left Africa.

Related Articles

Archaeological dig at Bronze Age Arkaim uncovering sheep skeleton with visualized ancient plague DNA against Eurasian steppe landscape.
Image generated by AI

Ancient sheep DNA offers new clues to how a Bronze Age plague spread across Eurasia

Reported by AI Image generated by AI Fact checked

Researchers analyzing ancient DNA say they have detected the plague bacterium Yersinia pestis in the remains of a domesticated sheep from Arkaim, a Bronze Age settlement in the southern Ural region of present-day Russia. The team reports this is the first known identification of a Bronze Age plague lineage in a nonhuman host from that period, a finding that could help explain how an early, pre-flea-adapted form of plague traveled widely across Eurasia.

Scientists have reconstructed the genome of Treponema pallidum from a 5,500-year-old skeleton in Colombia, marking the oldest known instance of this bacterium linked to syphilis and related diseases. The ancient strain diverged early in the pathogen's evolution, suggesting treponemal infections were diversifying in the Americas millennia before European contact. This discovery extends the genetic history of these diseases by over 3,000 years.

Reported by AI

Scientists have identified the oldest confirmed human RNA virus in lung tissue from a woman who died in London around the 1770s. The rhinovirus, which causes the common cold, was reconstructed from fragmented genetic material preserved in alcohol. This discovery opens new possibilities for studying the evolution of RNA viruses in human history.

An international team of researchers has used ancient DNA to diagnose a rare genetic growth disorder in two individuals buried together over 12,000 years ago in southern Italy. The analysis reveals that the younger person suffered from acromesomelic dysplasia, while her likely mother had a milder form of short stature. This discovery highlights the deep history of rare genetic conditions in human populations.

Reported by AI Fact checked

Penn State researchers report a bacterial defense that repurposes dormant viral DNA: a recombinase enzyme called PinQ flips a stretch of genome to produce protective proteins that block infection, work described in Nucleic Acids Research.

Researchers at the Swedish Centre for Palaeogenetics have analyzed DNA from an extinct woolly rhinoceros found in the stomach of a frozen wolf pup. The discovery, the first of its kind from the Ice Age, provides new clues about the species' extinction. The analysis suggests climate change likely caused the rhinoceros's disappearance rather than human hunting.

Reported by AI

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline